| Financial Year |
March 31 2023 |
| Monetary Funds |
2,888,057,173.15 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
535,865,624.80 |
| Advances to Suppliers |
1,603,282,943.03 |
| Other Receivables |
136,146,264.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,251,793,499.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
188,457,439.91 |
| Total Current Assets |
8,938,843,728.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
29,703,982.15 |
| Investment Properties |
11,597,719.27 |
| Fixed Assetes |
4,761,497,759.14 |
| Under-construction Projects |
2,399,233,761.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
524,530.94 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,179,483,995.99 |
| R&D expenses |
-- |
| Goodwill |
31,734,786.55 |
| Long-Term Deferred and Prepaid Expenses |
311,067,850.33 |
| Deferred Income Tax Assets |
104,021,316.85 |
| Other Non-Current Assets |
561,613,894.84 |
| Sub-Total of Non-Current Assets |
9,950,340,098.99 |
| Total Assets |
18,889,183,827.22 |
| Short-Term Loans |
2,725,500,000.00 |
| Trading Financial liabilities |
237,202.90 |
| Notes Payable |
1,194,000,000.00 |
| Accounts Payable |
1,071,034,384.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,053,417.87 |
| Taxes Payable |
149,180,290.49 |
| Interest Payable |
-- |
| Dividend Payable |
5,829,476.58 |
| Other payables |
160,775,115.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,025,975,331.73 |
| Other Current Liabilities |
212,342,854.90 |
| Sub-Total of Current Liabilities |
8,706,814,981.95 |
| Long-term Loans |
1,850,250,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
40,471,020.67 |
| Special Payable |
-- |
| Estimatied Liabilities |
10,157,940.24 |
| Deferred Income Tax Liabilities |
21,014,574.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,040,575,616.44 |
| Total Liabilities |
10,747,390,598.39 |
| Paid-In Capital(Or Share Stock) |
1,207,723,762.00 |
| Capital Surplus |
2,970,568,685.19 |
| Surplus Reserve |
260,082,205.84 |
| LESS:Treasury Stock |
56,258,587.75 |
| Undistributed Profits |
3,617,744,866.08 |
| Minority Stockholder's Interest |
79,738,264.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,062,054,964.51 |
| Owner's Equity（Stockholder's Equity） |
8,141,793,228.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,889,183,827.22 |
